Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...

EU-branded medicines face 15% import tariff; certain generic drugs might be exempt Tariffs may raise consumer prices unless mitigated, analyst says Pharma companies stockpile, make deals to absorb ...